Chemokines in Renal Injury
Open Access
- 1 May 2011
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 22 (5), 802-809
- https://doi.org/10.1681/asn.2010050510
Abstract
The main function of chemokines is to guide inflammatory cells in their migration to sites of inflammation. During the last 2 decades, an expanding number of chemokines and their receptors have driven broad inquiry into how inflammatory cells are recruited in a variety of diseases. Although this review focuses on chemokines and their receptors in renal injury, proinflammatory IL-17, TGFβ, and TWEAK signaling pathways also play a critical role in their expression. Recent studies in transgenic mice as well as blockade of chemokine signaling by neutralizing ligands or receptor antagonists now allow direct interrogation of chemokine action. The emerging role of regulatory T cells and Th17 cells during renal injury also forges tight relationships between chemokines and T cell infiltration in the development of kidney disease. As chemokine receptor blockade inches toward clinical use, the field remains an attractive area with potential for unexpected opportunity in the future.Keywords
This publication has 98 references indexed in Scilit:
- Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidneyKidney International, 2010
- Chemokines and chemokine receptors: new insights into cancer-related inflammationTrends in Molecular Medicine, 2010
- IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-α and IL-1βAmerican Journal of Physiology-Renal Physiology, 2010
- TWEAK Activates the Non-Canonical NFκB Pathway in Murine Renal Tubular Cells: Modulation of CCL21PLOS ONE, 2010
- IL-17 produced by neutrophils regulates IFN-γ–mediated neutrophil migration in mouse kidney ischemia-reperfusion injuryJCI Insight, 2010
- Considering TWEAK as a target for therapy in renal and vascular injuryCytokine & Growth Factor Reviews, 2009
- The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia–reperfusion injuryKidney International, 2008
- Selective CCR2-targeted macrophage depletion ameliorates experimental mesangioproliferative glomerulonephritisClinical and Experimental Immunology, 2008
- T-bet Deficiency Attenuates Renal Injury in Experimental Crescentic GlomerulonephritisJournal of the American Society of Nephrology, 2008
- CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cellsThe Journal of Experimental Medicine, 2007